ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SN. Smith & Nephew Plc

982.60
-32.40 (-3.19%)
23 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -32.40 -3.19% 982.60 984.60 985.00 1,010.50 981.00 1,010.50 4,001,268 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Ortho,prosth,surg Appl,suply 5.55B 263M 0.3011 32.71 8.6B
Smith & Nephew Plc is listed in the Ortho,prosth,surg Appl,suply sector of the London Stock Exchange with ticker SN.. The last closing price for Smith & Nephew was 1,015p. Over the last year, Smith & Nephew shares have traded in a share price range of 887.00p to 1,284.00p.

Smith & Nephew currently has 873,398,889 shares in issue. The market capitalisation of Smith & Nephew is £8.60 billion. Smith & Nephew has a price to earnings ratio (PE ratio) of 32.71.

Smith & Nephew Share Discussion Threads

Showing 1001 to 1023 of 1325 messages
Chat Pages: Latest  41  40  39  38  37  36  35  34  33  32  31  30  Older
DateSubjectAuthorDiscuss
12/8/2021
11:49
Bought a few today. Gotta b cheap.
its the oxman
12/8/2021
10:49
Ian, when S&N say the numbers are the
correct interpretation of the guidance
it gives a certain validity to the figures.

basildublin
12/8/2021
10:49
Ian, when S&N say the numbers are the
correct interpretation of the guidance
it gives a certain validity to the figures.

basildublin
12/8/2021
10:18
Thank you, nothing wrong with doing your own research particularly when you can justify the end result to your own satisfaction.
ianood
12/8/2021
08:32
Ian I am a CA
I took the information supplied with H2
Accounts, asked questions of S&N, got prompt replies, finished up with Trading Profits
between +37% and +49% over 2020 to which they agreed. Simple !
DYOR

basildublin
11/8/2021
23:33
Basil, thank you. Please what research does that pertain to?
ianood
11/8/2021
20:26
Hold on to your S&N shares.
2021 trading profits are projected to rise between 37% and 49%over 2020 !

basildublin
10/8/2021
22:36
EI, for what it's worth both ops, 3 years apart, were done under an epidural.

I do hold S&N, however, I suspect it may not be for too much longer!

ianood
10/8/2021
17:28
Ian, good to hear of that positive personal experience,
surgery under GA is not an option for me so mine better hold out!.

The posts not intended to deter anyone from buying here,
just for discussion purposes only. Always dyor etc.


Phil, lovely price.

essentialinvestor
10/8/2021
17:10
EI, Interesting comment, I have 2 Stryker knees installed via their robotic arm system which guarantees precision of 1mm in limb length and <1 degree deviation in the rotation of the knee from the norm. I did think that SN would be a good base from which Stryker could scale up in UK/Europe but now having seen and felt the product results I am thinking why would they bother, it will gravitate to them by results alone! Also the Stryker system makes component parts comparatively easy to replace and therefore not a complete TKR in the extremely rare event of a failure!
ianood
10/8/2021
16:50
Afternoon EI.

Showing my age here but I remember first buying these at 180p . Had them in a 'Single Company' PEP :-)

philanderer
10/8/2021
15:45
Look through the director dealing announcements over the last 6 months.
A couple of senior employees in leadership roles appear to have sold and
now don't seem to hold a single share in the Company?.

That being said, now trading at a level I mentioned a few months back as a target price.

There is no comparison with Stryker, it's risible to even mention the two in
the same breath. Stryker's record is exceptional.

Also worth considering some of the broker views, SN. lack a cementless knee product
ATM and this is arguable proving costly.

But ultimately the shares are no where near cheap even at current levels.
Speculative buy at best Imv.

essentialinvestor
10/8/2021
12:39
Questor: it’s not immune from inflation but Smith & Nephew is a quality business. Keep buying

Questor share tip: the medical equipment specialist is still recording high-teens operating margins even when it is not quite on top form

philanderer
09/8/2021
09:46
imo a good move ygor.
Sold my holding in digs which is currently under offer and invested the proceeds here - more than doubled my holding.
sn. looks good value and tbh I can't see much downside from here.
Suet

suetballs
09/8/2021
08:26
Opened a position here this morning. I have been tracking the US equivalent of S&N (Stryker) over the last month or so and its latest numbers published a week or so ago indicated a strong recovery. I do wonder about the quality of the management here but as others have said S&N is a quality business and so even if the current leadership can't run the business properly there are others who can. There has been a big fall here and potential US predators are active.
ygor705
06/8/2021
10:30
Happy to buy in here at 13.80, there might be further downside, upon which I would add more. This is a quality company in a long term uptrend selling products the world needs and will need in increasing volumes.
andyj
06/8/2021
08:55
All her shares! Is she leaving?
timbo_slice
05/8/2021
11:44
Chunky director share sale if I'm reading that correctly/
essentialinvestor
03/8/2021
13:18
Essential investor called this right
spoole5
29/7/2021
14:03
Bought in today at 1470p like the story here results were good will be 1650p plus soon enough gla
finkie
29/7/2021
12:18
..Guidance assumes surgery volumes largely unconstrained by COVID in second half of 2021..


Draw your own conclusions!.


As mentioned back in June there may be better opportunities to add.

Under £14 may be worth a look.

essentialinvestor
29/7/2021
10:43
Well they are recovering, but what a woeful list of "headwinds". No wonder the price has plunged!
bigbertie
14/7/2021
15:08
Hopefully the results will kick this on
spoole5
Chat Pages: Latest  41  40  39  38  37  36  35  34  33  32  31  30  Older

Your Recent History

Delayed Upgrade Clock